Literature DB >> 15803007

Contouring the middle and inner ear on radiotherapy planning scans.

Heather D Pacholke1, Robert J Amdur, Ilona M Schmalfuss, Debbie Louis, William M Mendenhall.   

Abstract

The purpose of this study was to establish guidelines that help radiation oncologists contour the inner and middle ear on treatment planning scans. The radiotherapy computed tomography (CT) scans of 15 previously treated patients were reviewed for the ability to identify 3 separate auditory structures. The middle ear, the cochlea, and the vestibular apparatus were identified and contoured on each scan using anatomic landmarks. The volume and maximum axial dimension of each contour were calculated. The middle ear, cochlea, and vestibular apparatus were identified on all scans. The middle ear was defined by the tympanic membrane laterally and by the interface between air and the temporal bone in all other directions. The plane of the internal auditory canal through the temporal bone was the landmark distinguishing the vestibular apparatus from the cochlea. The mean volume of the middle ear, vestibular apparatus, and cochlea were 0.58 cm3, 0.44 cm3, and 0.14 cm3, respectively. The maximum axial dimension across the contour averaged 1.57 cm for the middle ear, 1.10 cm for the vestibular apparatus, and 0.69 cm for the cochlea. A reference atlas was constructed that shows the contour of each structure on 5 consecutive CT images. Accurate identification of the middle ear and inner ear structures on radiotherapy planning scans is possible and is necessary if critical auditory organs are to be spared during radiotherapy of targets that are located near the base of the skull. The information generated in this study will help radiation oncologists contour auditory structures accurately.

Entities:  

Mesh:

Year:  2005        PMID: 15803007     DOI: 10.1097/01.coc.0000143847.57027.16

Source DB:  PubMed          Journal:  Am J Clin Oncol        ISSN: 0277-3732            Impact factor:   2.339


  14 in total

Review 1.  Radiation therapy and hearing loss.

Authors:  Niranjan Bhandare; Andrew Jackson; Avraham Eisbruch; Charlie C Pan; John C Flickinger; Patrick Antonelli; William M Mendenhall
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-03-01       Impact factor: 7.038

2.  Increased cochlear radiation dose predicts delayed hearing loss following both stereotactic radiosurgery and fractionated stereotactic radiotherapy for vestibular schwannoma.

Authors:  Kunal S Patel; Edwin Ng; Taranjit Kaur; Tyler Miao; Tania Kaprealian; Percy Lee; Nader Pouratian; Michael T Selch; Antonio A F De Salles; Quinton Gopen; Stephen Tenn; Isaac Yang
Journal:  J Neurooncol       Date:  2019-09-24       Impact factor: 4.130

Review 3.  Organ-sparing radiation therapy for head and neck cancer.

Authors:  XiaoShen Wang; ChaoSu Hu; Avraham Eisbruch
Journal:  Nat Rev Clin Oncol       Date:  2011-07-26       Impact factor: 66.675

Review 4.  The biology of radiosurgery and its clinical applications for brain tumors.

Authors:  Douglas Kondziolka; Samuel M Shin; Andrew Brunswick; Irene Kim; Joshua S Silverman
Journal:  Neuro Oncol       Date:  2014-09-28       Impact factor: 12.300

5.  SmartArc-based volumetric modulated arc therapy can improve the middle ear, vestibule and cochlea sparing for locoregionally advanced nasopharyngeal carcinoma: a dosimetric comparison with step-and-shoot intensity-modulated radiotherapy.

Authors:  J Gao; T-L Qian; C-Z Tao; Y-H Zhang; Y Zhou; J Yang; J He; R Wang; P-J Zhou
Journal:  Br J Radiol       Date:  2015-06-25       Impact factor: 3.039

6.  Adverse Cochlear Effects After Head and Neck Cancer Therapy.

Authors:  Vanita Sarin
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2018-11-30

7.  Prospective assessment of an atlas-based intervention combined with real-time software feedback in contouring lymph node levels and organs-at-risk in the head and neck: Quantitative assessment of conformance to expert delineation.

Authors:  Musaddiq Awan; Jayashree Kalpathy-Cramer; G Brandon Gunn; Beth M Beadle; Adam S Garden; Jack Phan; Emma Holliday; William E Jones; Elizabeth Maani; Abhilasha Patel; Jehee Choi; Virginia Clyburn; Bundhit Tantiwongkosi; David I Rosenthal; Clifton D Fuller
Journal:  Pract Radiat Oncol       Date:  2012-12-21

8.  A pilot prospective feasibility study of organ-at-risk definition using Target Contour Testing/Instructional Computer Software (TaCTICS), a training and evaluation platform for radiotherapy target delineation.

Authors:  Jayashree Kalpathy-Cramer; Steven D Bedrick; Kelly Boccia; Clifton D Fuller
Journal:  AMIA Annu Symp Proc       Date:  2011-10-22

9.  Hearing evaluation of patients with head and neck cancer: Comparison of Common Terminology Criteria for Adverse Events, Brock and Chang adverse event criteria in patients receiving cisplatin.

Authors:  A Dimitrios Colevas; Ruth R Lira; Electra A Colevas; Philip W Lavori; Cato Chan; David B Shultz; Kay W Chang
Journal:  Head Neck       Date:  2014-07-11       Impact factor: 3.147

10.  Unilateral cochlea sparing in locoregionally advanced head and neck cancer: a planning study.

Authors:  L H Braun; K Braun; B Frey; S M Wolpert; H Löwenheim; D Zips; S Welz
Journal:  Strahlenther Onkol       Date:  2018-08-14       Impact factor: 3.621

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.